Navigation Links
Dana-Farber Cancer Institute Commences Phase 1 Trial With EntreMed's Selective Kinase Inhibitor
Date:5/8/2008

REF="http://www.entremed.com" target="_new">http://www.entremed.com and in various filings with the Securities and Exchange Commission.

Forward Looking Statements

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act with respect to the outlook for expectations for future financial or business performance (including the timing of royalty revenues and future R&D expenditures), strategies, expectations and goals. Forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Forward-looking statements speak only as of the date they are made, and no duty to update forward-looking statements is assumed. Actual results could differ materially from those currently anticipated due to a number of factors, including those set forth in Securities and Exchange Commission filings under "Risk Factors," including risks relating to the need for additional capital and the uncertainty of additional funding; variations in actual sales of Thalomid(R), risks associated with the Company's product candidates; the early-stage products under development; results in preclinical models are not necessarily indicative of clinical results, uncertainties relating to preclinical and clinical trials; success in the clinical development of any products; dependence on third parties; future capital needs; and risks relating to the commercialization, if any, of the Company's proposed products (such as marketing, safety, regulatory, patent, product liability, supply, competition and other risks).

CONTACT:

Ginny Dunn

Associate Director, Corporate Communications & Investor Relations

EntreMed, Inc.

240.864.2643


'/>"/>
SOURCE EntreMed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Johns Hopkins to add Elekta Synergy S(R) to Cancer Treatment Lineup
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. Novel Technology Breaks Through Cancer Pain
9. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
10. Pharmion and MethylGene Announce Collaboration to Develop Sirtuin Inhibitors as Anti-Cancer Agents
11. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/13/2014)... Boehringer Laboratories Inc., with a forty year history ... successful broadcast of a live surgery by St. Luke’s ... FAMBS, and Maher El Chaar, MD, FACS, FAMBS, using ... This sleeve gastrectomy surgery was performed and broadcast live ... surgeons from around the world during the 5th International ...
(Date:9/12/2014)... Sept. 12, 2014   Arthur Kay , the ... won the Postcode Lottery Green Challenge 2014. The jury, ... 500,000 ($680,000 USD) at the final in ... Kay,s company uses a patented process ... namely biodiesel and biomass pellets, used for powering buildings ...
(Date:9/12/2014)... DUBLIN , Sept. 12, 2014 ... the "Global Dry Film Photoresist Industry Report 2014" ... Global Dry Film Photoresist Industry Report 2014 is a ... the global dry film photoresist industry . ... including definitions, classifications, applications and industry chain structure. The ...
(Date:9/12/2014)... , September 12, 2014 On Thursday, ... 0.12%, the Dow Jones Industrial Average finished the day 0.12% ... up 0.09%. The gains were broad based as seven out ... 500 Health Care Sector Index ended the day at 741.83, ... last one month. Investor-Edge has initiated coverage on the following ...
Breaking Biology Technology:Boehringer Laboratories, Inc. Announces Live Surgery Using Innovative System to Calibrate Sleeve Gastrectomy 2Green Startup Bio-Bean Wins $680,000 in Postcode Lottery Green Challenge 2Green Startup Bio-Bean Wins $680,000 in Postcode Lottery Green Challenge 3Global Dry Film Photoresist Industry Report 2014 2Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics 2Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics 3Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics 4Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics 5
... A key lawmaker who often disagrees with Governor ... he saw nothing inappropriate about the governor's use of an ... stem cell companies. , ,Meanwhile, the executive order, signed Tuesday ... from the director of Pro Life Wisconsin. , ,Ted Kanavas, ...
... - The Wisconsin Department of Motor Vehicles has deployed ... out of crime. , ,Preventing mischief in the issuance of ... Alioto, a fraud prevention specialist with the DMV , ... like a Social Security card or a birth certificate, a ...
... you're not reading this column, at least not today. May ... on the planet of the contributions to society and economy ... thousands of people will take to the streets in support ... will stay home from work. Some plan to keep their ...
Cached Biology Technology:Republican sees nothing wrong with Doyle's use of executive order 2New DMV tool never forgets a face 2New DMV tool never forgets a face 3Technology and the "American" dream 2
(Date:9/15/2014)... When this week,s print issue of the journal ... up from New Mexico, Montana and even the Netherlands, ... more and more the norm in these connected times. ... it will produce innovations in biology, medicine, biotechnology and ... this scientist talked with that one, that one knew ...
(Date:9/15/2014)... Sonja Schmid, an assistant professor in the Department of ... Liberal Arts and Human Sciences at Virginia Tech, has ... (CAREER) Award to study the prospects and problems of ... catastrophic failure of Japan,s Fukushima I Nuclear Power Plant ... the scientific community viewed nuclear emergencies, Schmid said. Three ...
(Date:9/15/2014)... wild, domesticated, and domesticated-wild hybridized populations of ... that within 5 to 11 generations, selection ... populations that hybridized with domesticated populations. , ... evidence that natural selection, over time, removes ... as a result of increased genetic diversity. ...
Breaking Biology News(10 mins):Collaboration drives achievement in protein structure research 2'Nuclear disasters don't respect national boundaries' 2
... to local climates -- and potentially to climate change -- may ... to new research published in Science by UBC evolutionary ... resistance to local pests -- that has helped purple loosestrife to ... species to rapidly adapt to local climate has not generally been ...
... been invading Europe,s rivers and lakes for several decades, but ... and problematic, like so many other invaders - such as ... European shrimps have something to do with this? Jaimie ... and found it only existed where native shrimps were absent ...
... body of water, from a puddle or a pond to ... rocks, plants, and animals. These so-called sessile suspension feeders are ... cleaning up environmental contaminants by consuming bacteria. A study published ... Journal reveals that by actively changing the angle of ...
Cached Biology News:Adaptability to local climate helps invasive species thrive 2Predators vs. alien: European shrimps win predatory battles with an American invader 2How tiny organisms make a big impact on clean water 2
... a simple and convenient method for the rapid, ... been optimized for use with S. cerevisiae and ... fungus species that is susceptible to yeast lytic ... spheroplasts of yeast cells that are ideal for ...
Four siRNAs targeting your gene of interest, providing gene silencing with 100% satisfaction guaranteed High knockdown potency , High specificity for minimal off-target effects , Flexible siR...
... PHD2000 syringe pump series combines Harvard Apparatuss best ... and a wide range of configuration options. A ... dimensions of syringes from all the major manufacturers. ... all the pertinent information from across the lab. ...
... Drosophila S2 cells are used for heterologous ... System (DES). The S2 cell line was ... (20-24 hours old) Drosophila melanogaster embryos ... at room temperature without CO2 and is easily ...
Biology Products: